⌘K

Login Start Free

Home/Filings/4/0001250023-05-000010

4//SEC Filing

SCICLONE PHARMACEUTICALS INC 4

Accession 0001250023-05-000010

CIK 0000880771operating

View on SEC.gov Company Profile

Filed

May 31, 8:00 PM ET

Accepted

Jun 1, 6:11 PM ET

Size

32.4 KB

Accession

0001250023-05-000010

Insider Transaction Report

Form 4

Period: 2005-05-29

SCICLONE PHARMACEUTICALS INCSCLN

Director

Transactions

Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2005-05-29−20,000→ 0 total
Exercise: $3.84Exp: 2012-05-30→ Common Stock (20,000 underlying)
Award
Non-Qualified Stock Option (right to buy)
2005-05-29+20,000→ 20,000 total
Exercise: $3.84Exp: 2012-05-30→ Common Stock (20,000 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2005-05-29−10,000→ 0 total
Exercise: $3.69Exp: 2008-06-26→ Common Stock (10,000 underlying)
Award
Non-Qualified Stock Option (right to buy)
2005-05-29+10,000→ 10,000 total
Exercise: $3.69Exp: 2008-06-26→ Common Stock (10,000 underlying)
Disposition to Issuer
Non-Qualified Stock Option (right to buy)
2005-05-29−30,000→ 0 total
Exercise: $5.23Exp: 2014-05-26→ Common Stock (30,000 underlying)
Award
Non-Qualified Stock Option (right to buy)
2005-05-29+30,000→ 30,000 total
Exercise: $5.23Exp: 2014-05-26→ Common Stock (30,000 underlying)

Footnotes (1)

[F1]Amendment of outstanding option to extend the post-termination exercise period resulting in deemed cancellation of option and grant of replacement option. Options are fully vested and exercisable.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

SCICLONE PHARMACEUTICALS INC

CIK 0000880771

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000880771

Filing Metadata

Form type: 4
Filed: May 31, 8:00 PM ET
Accepted: Jun 1, 6:11 PM ET
Size: 32.4 KB

View on SEC.gov